Nelarabine Injection
Product Images NDC 81927-375

6 FDA label images from Shorla Oncology Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Nelarabine (NDC 81927-375). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Shorla Oncology Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure01)

Structure (Structure01)
Chemical structure of nelarabine, showing a purine nucleoside analog with methoxy, amino, and hydroxyl functional groups attached to a sugar moiety.*
FDA Label Image

Label (Label01 V2)

Label (Label01 V2)
Nelarabine Injection 250 mg/50 mL (5 mg/mL) intravenous infusion single-dose vial label. The label states it is for intravenous infusion only, with a 50 mL vial. Manufactured by AqVida GmbH in Germany and distributed by Shorla Oncology Inc. Storage and inactive ingredients (sodium chloride, water for injection) information are provided, along with a barcode and space for lot and expiration dates.*
FDA Label Image

Carton (Carton01 V2)

Carton (Carton01 V2)
Label for Nelarabine Injection 250 mg/50 mL (5 mg/mL) intravenous injection by Shorla Oncology Inc. The label includes dosing concentration, storage instructions, inactive ingredients, and manufacturing details. It also displays the NDC number 81927-111-01, a barcode, and usage instructions indicating it is for single-dose vial use with discard of unused portion.*
FDA Label Image

Carton (Carton2 V3)

Carton (Carton2 V3)
The packaging label for Nelarabine Injection, 250 mg/50 mL (5 mg/mL), an intravenous injection by Shorla Oncology Inc. The label indicates it contains six single-dose vials and instructs to discard unused portion. Additional details include manufacturer info (AqVida GmbH, Germany), storage instructions, and inactive ingredients.*
FDA Label Image

Label (Image01)

Label (Image01)
Label for Nelarabine Injection 375 mg/75 mL (5 mg/mL) for intravenous infusion. The single-dose vial contains 75 mL. The label indicates no preservatives and includes storage instructions. Manufactured by AqVida GmbH, Germany, and distributed by Shorla Oncology Inc., Cambridge, MA. Barcode and some inactive ingredients are listed.*
FDA Label Image

Carton (Image02)

Carton (Image02)
Packaging label for Nelarabine Injection 375 mg/75 mL (5 mg/mL), an intravenous injection by Shorla Oncology Inc. The carton includes dosing and storage instructions, barcode, NDC 81927-375-01, and manufacturer details. It specifies a single-dose 75 mL vial with directions to discard unused portions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.